# Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis

> **NCT02505113** · — · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 150 (estimated)

## Conditions studied

- Portal Vein, Cavernous Transformation Of

## Interventions

- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT02505113
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2020-12
- **Final completion:** —
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505113, "Cavernous Transformation of Portal Vein： Etiology, Diagnosis, Management and Prognosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02505113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*